According to the authors, the two clear benefits for this type of drug delivery are: supplementing IV with subcutaneous administration and substituting subcutaneous administration for IV. This type of delivery gives the freedom of choosing when and where the drug delivery will take place. Other benefits of this type of drug delivery method are auto-fill from standard primary container, controlled delivery of large volume, platform for multiple applications, optimising pharmacokinetics, cost efficiency, and advanced proprietary features.
With a drug delivery device like this, what do you think are the main advantages of putting the control of the drug delivery devices into the hands of the patients?
No comments:
Post a Comment